News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
235,715 Results
Type
Article (16061)
Company Profile (69)
Press Release (219585)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (68044)
Career Advice (365)
Deals (10550)
Drug Delivery (15)
Drug Development (31285)
Employer Resources (22)
FDA (6846)
Job Trends (5390)
News (119002)
Policy (11893)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (1273)
Academic (1)
Accelerated approval (1)
Allergies (38)
Alliances (20061)
ALS (34)
Alzheimer's disease (486)
Antibody-drug conjugate (ADC) (38)
Approvals (6933)
Artificial intelligence (111)
Autoimmune disease (5)
Automation (11)
Bankruptcy (56)
Best Places to Work (4458)
BIOSECURE Act (4)
Biosimilars (39)
Biotechnology (52)
Bladder cancer (37)
Brain cancer (13)
Breast cancer (129)
Cancer (1064)
Cardiovascular disease (60)
Career advice (320)
Career pathing (8)
CAR-T (52)
Cell therapy (137)
Cervical cancer (10)
Clinical research (25145)
Collaboration (386)
Compensation (91)
Complete response letters (7)
COVID-19 (1150)
CRISPR (16)
C-suite (89)
Cystic fibrosis (39)
Data (1027)
Denatured (2)
Depression (5)
Diabetes (78)
Diagnostics (4662)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (62)
Drug pricing (8)
Drug shortages (3)
Duchenne muscular dystrophy (38)
Earnings (23575)
Editorial (7)
Employer branding (4)
Employer resources (20)
Events (30220)
Executive appointments (260)
FDA (7293)
Featured Employer (20)
Frontotemporal dementia (3)
Funding (250)
Gene editing (35)
Generative AI (14)
Gene therapy (110)
GLP-1 (258)
Government (1564)
Grass and pollen (3)
Guidances (22)
Healthcare (5428)
Huntington's disease (5)
IgA nephropathy (8)
Immunology and inflammation (28)
Indications (19)
Infectious disease (1215)
Inflammatory bowel disease (60)
Inflation Reduction Act (1)
Influenza (26)
Intellectual property (31)
Interviews (45)
IPO (4303)
IRA (3)
Job creations (1187)
Job search strategy (299)
Kidney cancer (5)
Labor market (5)
Layoffs (114)
Leadership (2)
Legal (1768)
Liver cancer (29)
Lung cancer (178)
Lymphoma (74)
Machine learning (2)
Management (7)
Manufacturing (101)
MASH (28)
Medical device (3272)
Medtech (3272)
Mergers & acquisitions (6402)
Metabolic disorders (203)
Multiple sclerosis (27)
NASH (11)
Neurodegenerative disease (33)
Neuropsychiatric disorders (2)
Neuroscience (661)
NextGen: Class of 2025 (1518)
Non-profit (1044)
Northern California (1043)
Now hiring (14)
Obesity (104)
Opinion (55)
Ovarian cancer (30)
Pain (19)
Pancreatic cancer (31)
Parkinson's disease (55)
Partnered (8)
Patents (71)
Patient recruitment (32)
Peanut (22)
People (20835)
Pharmaceutical (13)
Phase I (7240)
Phase II (10375)
Phase III (9706)
Pipeline (499)
Policy (23)
Postmarket research (1032)
Preclinical (3785)
Press Release (52)
Prostate cancer (53)
Psychedelics (4)
Radiopharmaceuticals (107)
Rare diseases (139)
Real estate (2677)
Recruiting (7)
Regulatory (9391)
Reports (11)
Research institute (1314)
Resumes & cover letters (46)
Rett syndrome (2)
RNA editing (2)
RSV (14)
Schizophrenia (12)
Series A (47)
Series B (34)
Service/supplier (1)
Sickle cell disease (21)
Southern California (768)
Spinal muscular atrophy (98)
Sponsored (10)
Startups (1376)
State (1)
Stomach cancer (3)
Supply chain (16)
Tariffs (8)
The Weekly (9)
United States (7538)
Vaccines (234)
Venture capitalists (8)
Weight loss (54)
Women's health (9)
Worklife (3)
Date
Today (10)
Last 7 days (156)
Last 30 days (840)
Last 365 days (12220)
2025 (3392)
2024 (12983)
2023 (14970)
2022 (19982)
2021 (21088)
2020 (18834)
2019 (14243)
2018 (11012)
2017 (12737)
2016 (11957)
2015 (13703)
2014 (10226)
2013 (8583)
2012 (9466)
2011 (9580)
2010 (8335)
Location
Africa (244)
Alabama (13)
Alaska (2)
Arizona (58)
Arkansas (3)
Asia (14674)
Australia (2419)
California (2196)
Canada (523)
China (200)
Colorado (72)
Connecticut (91)
Delaware (68)
Europe (43422)
Florida (193)
Georgia (30)
Idaho (11)
Illinois (124)
India (16)
Indiana (86)
Iowa (2)
Japan (65)
Kansas (28)
Kentucky (5)
Louisiana (2)
Maine (27)
Maryland (244)
Massachusetts (1547)
Michigan (87)
Minnesota (98)
Missouri (49)
Montana (11)
Nebraska (4)
Nevada (5)
New Hampshire (13)
New Jersey (678)
New Mexico (14)
New York (600)
North Carolina (279)
North Dakota (4)
Northern California (1043)
Ohio (92)
Oklahoma (5)
Oregon (17)
Pennsylvania (300)
Puerto Rico (1)
Rhode Island (14)
South America (318)
South Carolina (5)
Southern California (768)
Tennessee (23)
Texas (313)
Utah (92)
Virginia (36)
Washington D.C. (13)
Washington State (192)
Wisconsin (15)
235,715 Results for "european molecular biology laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development
April 7, 2025
·
3 min read
Press Releases
Molecular Instruments’® RNA In Situ Hybridization (RNA-ISH) Technology Enables Breakthrough Laboratory-Developed Tests (LDTs) to Advance Precision Medicine for Inflammatory Skin Disease
February 12, 2025
·
4 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Virscio Extends Translational Expertise and Research Services to Molecular Biology
October 22, 2024
·
1 min read
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that will apply to all EU member states as well as Norway, Liechtenstein and Iceland.
March 3, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.
The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million patients* in Europe.
June 28, 2024
·
2 min read
Press Releases
Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism
April 17, 2025
·
8 min read
Press Releases
AMDI Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular Diagnostics
April 14, 2025
·
1 min read
Press Releases
BostonGene to Participate in the European Federation of Laboratory Medicine Strategic Conference 2024
September 19, 2024
·
2 min read
1 of 23,572
Next
